|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 31, 2017 ) Ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.
The global ophthalmology drugs market was estimated to be around $26 billion as of 2016. The ophthalmology drugs market market made up around 2.5% of the overall pharmaceuticals market in 2016. The ophthalmology drugs market was the smallest market in the global pharmaceutical market in 2016.
For more information about this report at http://www.reportsweb.com/ophthalmology-drugs-market-global-report-2017
Development Of Combination Therapies
Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890209/sample
Table of Content
1. Ophthalmology Drugs Market Characteristics
2. Ophthalmology Drugs Market Size And Growth
3. Pestle Analysis
4. Ophthalmology Drugs Market Customer Information
5. Ophthalmology Drugs Market Segmentation
6. Ophthalmology Drugs Market Regional And Country Analysis
7. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors
8. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries
9. Ophthalmology Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Ophthalmology Drugs Market
11. Western Europe Ophthalmology Drugs Market
12. Eastern Europe Ophthalmology Drugs Market
13. North America Ophthalmology Drugs Market
14. South America Ophthalmology Drugs Market
15. Middle East Ophthalmology Drugs Market
16. Africa Ophthalmology Drugs Market
17. Ophthalmology Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Ophthalmology Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890209/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
